An analytical GC-MS method to quantify methyl dihydrojasmonate in biocompatible oil-in-water microemulsions: physicochemical characterization and in vitro release studies

• Autor(a) principal: da Silva, Gisela Bevilacqua Rolfsen Ferreira [UNESP]
• Data de Publicação: 2018
• Outros Autores: Alécio, Alberto Camilo [UNESP], Scarpa, Maria Virginia Costa [UNESP], do Egito, Eryvaldo Socrates Tabosa, Sequinel, Rodrigo [UNESP], Hatanaka, Rafael Rodrigues [UNESP], Oliveira, José Eduardo [UNESP], Oliveira, Anselmo Gomes de [UNESP]
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1080/10837450.2017.1337792; http://hdl.handle.net/11449/174791
• topic: analytical GC-MS method; antitumor drug; biocompatible microemulsions; in vitro release; Methyl dihydrojasmonate

Microemulsions (MEs) loaded with methyl dihydrojasmonate (MJ) were developed to improve the aqueous solubility of this drug. The composition of the formulations ranged according to the oil/surfactant ratio (O/S). The MEs were characterized according to diameter of droplets, X-ray diffraction and polarized light microscopy. The MJ identification and quantification was performed by gas chromatography-mass spectrometry (GC-MS). The MJ showed a retention time of ∼16.7 min for all samples. The obtained correlation coefficient from the calibration graph was 0.991. The developed analytical method was effective enough to quantify low and high concentrations of MJ. The increase of the O/S ME ratio led to a reduction of the droplet diameter. All formulations showed an amorphous structure and the behavior varied between isotropic and anisotropic systems. A decrease in the release of MJ with the increase of the O/S ratio in the formulations was observed. The analytical method developed for the quantitative determination of MJ is suitable to detect and quantify the drug compound from different compositions of MEs in the in vitro release test, and by analogy in other prolonged effects related to the drug reservoir effect of these systems was observed, revealing that ME can be a promising nanocarrier for MJ delivery to tumor cells.